In vitro consultation cancer screening and targeted anticancer drug research and development
Investors 3
Mentions in press and media 1
| Date | Title | Description |
| 06.10.2022 | BIOINFRA and 20/20 GeneSystems Announce U.S. Technology License for Enhanced Multi-Cancer Early Detection Blood Test | Additional biomarkers and algorithm expected to improve diagnostic accuracy as interest in Multi-Cancer Early Detection (MCED) grows in the U.S. GAITHERSBURG, MD, UNITED STATES, October 6, 2022 /EINPresswire.com/ -- BIOINFRA Life Sciences L... |